Order Article Reprints

Pedrani M, Salfi G, Merler S, Testi I, Agrippina Clerici CM, Pecoraro G, Castelo-Branco L, Turco F, Tortola L, Vogl U, et al. Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting. International Journal of Molecular Sciences. 2025; 26(11):5309. https://doi.org/10.3390/ijms26115309

Pedrani, Martino, Giuseppe Salfi, Sara Merler, Irene Testi, Chiara Maria Agrippina Clerici, Giovanna Pecoraro, Luis Castelo-Branco, Fabio Turco, Luigi Tortola, Ursula Vogl, and et al. 2025. "Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting" International Journal of Molecular Sciences 26, no. 11: 5309. https://doi.org/10.3390/ijms26115309

Pedrani, M., Salfi, G., Merler, S., Testi, I., Agrippina Clerici, C. M., Pecoraro, G., Castelo-Branco, L., Turco, F., Tortola, L., Vogl, U., Gillessen, S., Theurillat, J.-P., Zilli, T., & Mestre, R. P. (2025). Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting. International Journal of Molecular Sciences, 26(11), 5309. https://doi.org/10.3390/ijms26115309